NewGenIvf Group (NASDAQ:NIVF) Upgraded at Wall Street Zen

NewGenIvf Group (NASDAQ:NIVF) was upgraded by equities research analysts at Wall Street Zen to a “hold” rating in a research report issued to clients and investors on Saturday.

Separately, Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a research report on Friday, October 31st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, NewGenIvf Group presently has an average rating of “Sell”.

NewGenIvf Group Price Performance

NewGenIvf Group stock opened at $1.45 on Friday. NewGenIvf Group has a 52-week low of $1.21 and a 52-week high of $2,735.00. The company has a debt-to-equity ratio of 0.17, a quick ratio of 2.17 and a current ratio of 3.43. The business has a 50-day simple moving average of $4.84 and a two-hundred day simple moving average of $16.98.

NewGenIvf Group Company Profile

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services.